Clinical predictors of advanced fibrosis in patient with non-alcoholic fatty liver disease (NAFLD)

被引:0
|
作者
Siua, W. [1 ,2 ]
Andiganib, M. [1 ,2 ]
Frasera, A. [1 ,2 ]
Vijayana, B. [1 ,2 ]
Mclemana, L. [1 ,2 ]
Englisha, S. [1 ,2 ]
Mukhopadhyaa, A. [1 ,2 ]
机构
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
[2] Univ Aberdeen, Aberdeen, Scotland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-0861
引用
收藏
页码:187 / 187
页数:1
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [42] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    [J]. Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [43] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    [J]. CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [44] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [45] Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Burra, Patrizia
    Bizzaro, Debora
    Gonta, Anna
    Shalaby, Sarah
    Gambato, Martina
    Morelli, Maria Cristina
    Trapani, Silvia
    Floreani, Annarosa
    Marra, Fabio
    Brunetto, Maurizia Rossana
    Taliani, Gloria
    Villa, Erica
    [J]. LIVER INTERNATIONAL, 2021, 41 (08) : 1713 - 1733
  • [46] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 703 - 703
  • [47] Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Alejandro Campos-Murguía
    Astrid Ruiz-Margáin
    José A González-Regueiro
    Ricardo U Macías-Rodríguez
    [J]. World Journal of Gastroenterology, 2020, (39) : 5919 - 5943
  • [48] Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Campos-Murguia, Alejandro
    Ruiz-Margain, Astrid
    Gonzalez-Regueiro, Jose A.
    Macias-Rodriguez, Ricardo U.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (39) : 5919 - 5943
  • [49] Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
    Han, Eugene
    [J]. DIABETES & METABOLISM JOURNAL, 2022, 46 (04) : 564 - 566
  • [50] Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
    Yanavich, C.
    Pacheco, A.
    Cardoso, S.
    Nunes, E.
    Chaves, U.
    Santos, R.
    Morata, M.
    Veloso, V. G.
    Grinsztejn, B.
    Perazzo, H.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 5 - 6